Shiv Kumar Sarin, Ashok Choudhury, Manoj K. Sharma, Rakhi Maiwall et al.
The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in 2009. With international groups volunteering to join, the “APASL ACLF Research Consortium (AARC)” was formed in...
Ridwanur Rahman, Vishal Goyal, Rashidul Haque, Kazi M. Jamil et al.
BACKGROUND: AmBisome therapy for VL has an excellent efficacy and safety profile and has been adopted as a first-line regimen in Bangladesh. Second-line treatment options are limited and should preferably be given in short course combinations in order to prevent the development of resistant strains....
Bruce Biccard, Denton Smith, Shrikant Peters, Adam Boutall et al.
<h3>Background</h3> This study assessed the potential cost-effectiveness of high (80–100%) <i>vs</i> low (21–35%) fraction of inspired oxygen (FiO<sub>2</sub>) at preventing surgical site infections (SSIs) after abdominal surgery in Nigeria, India, and South Africa. <h3>Methods</h3> Decision-analyti...
Mohammad Afzal, Faheem Ahamad, Syed Aqeel Ahmad, Shaheen Efrah Ali et al.
Vishal Goyal
Introduction In 2010, WHO recommended changing national policy to prevent the emergence of resistance to monotherapy drugs in visceral leishmaniasis (VL), and specifically, to phase out miltefosine monotherapy. We planned a Phase III clinical trial in Bangladesh and a field implementation study in I...